,ticker,date,time,headline,neg,neu,pos,compound
0,ABT,2021-04-13,05:50PM,Abbott (ABT) Outpaces Stock Market Gains: What You Should Know,0.0,0.789,0.211,0.34
1,ABT,2021-04-13,12:30PM,Abbott (ABT) Earnings Expected to Grow: Should You Buy?,0.0,1.0,0.0,0.0
2,ABT,2021-04-13,08:55AM,Demand for Nutrition Line to Drive Abbott (ABT) Q1 Earnings,0.143,0.857,0.0,-0.128
3,ABT,2021-04-12,09:19AM,Abbott (ABT) Gets Europe Nod for TriClip G4 to Treat TR,0.0,0.787,0.213,0.4019
4,ABT,2021-04-12,08:00AM,World's Fastest Marathoner Eliud Kipchoge Uses Abbott's Libre Sense at NN Mission Marathon Qualifier Race for the Olympic Games,0.0,1.0,0.0,0.0
5,ABT,2021-04-10,09:00AM,Why Abbott Labs Will Make You Richer in April (and Beyond!),0.0,0.73,0.27,0.5707
6,ABT,2021-04-09,04:06PM,Abbott Ireland Financing DAC -- Moody's announces completion of a periodic review of ratings of Abbott Laboratories,0.0,1.0,0.0,0.0
7,ABT,2021-04-08,01:38PM,Abbott's Upgraded TriClip Heart Valve System OK'd In Europe,0.0,1.0,0.0,0.0
8,ABT,2021-04-08,09:00AM,"Abbott Receives CE Mark Approval for Next-Generation TriClip Device, Offering New Innovations for Tricuspid Heart Valve Repair",0.0,0.838,0.162,0.4767
9,ABT,2021-04-08,07:18AM,"Zacks Market Edge Highlights: Facebook, Sony, Apple, Canada Goose and Abbott",0.0,1.0,0.0,0.0
10,ABT,2021-04-07,09:28AM,Abbott's (ABT) DAPT for High Bleeding Risk Gets Europe Nod,0.189,0.811,0.0,-0.2732
11,ABT,2021-04-06,09:00AM,Abbott's XIENCE Stent Receives European Approval for One-Month Dual Anti-Platelet Therapy (DAPT) for High Bleeding Risk Patients,0.104,0.743,0.153,0.25
12,ABT,2021-04-05,01:32PM,Consumer inflation poses the biggest risk to the market: Analyst,0.189,0.811,0.0,-0.2732
13,ABT,2021-04-05,09:47AM,Here's Why You Should Retain Abbott Laboratories (ABT) Stock,0.0,1.0,0.0,0.0
14,ABT,2021-04-05,09:22AM,Abbott's (ABT) BinaxNOW Test Gets FDA's EUA for Self Use,0.0,1.0,0.0,0.0
15,ABT,2021-04-01,09:42AM,"Pfizer, Biotech vaccine shows strong results after 6 months",0.0,0.68,0.32,0.5106
16,ABT,2021-04-01,08:55AM,Abbott-Quidel Rapid COVID-19 Test Cleared by FDA,0.0,0.811,0.189,0.1027
17,ABT,2021-04-01,07:32AM,Abbotts BinaxNOW COVID-19 Ag Self Test Cleared For Emergency Use In US,0.186,0.714,0.1,-0.296
18,ABT,2021-03-31,11:18PM,U.S. okays Abbott's rapid COVID-19 test for at-home screenings in those without symptoms,0.0,0.795,0.205,0.4767
19,ABT,2021-03-31,11:06PM,"Abbott's BinaxNOW Rapid Antigen Self Test Receives FDA Emergency Use Authorization for Asymptomatic, Over-the-Counter, Non-Prescription, Multi-Test Use",0.14,0.86,0.0,-0.3818
20,ABT,2021-03-30,06:40AM,These 3 Stocks Will Make You Rethink Your Portfolio,0.0,1.0,0.0,0.0
21,ABT,2021-03-29,11:30AM,Has Abbott Laboratories (ABT) Outpaced Other Medical Stocks This Year?,0.0,1.0,0.0,0.0
22,ABT,2021-03-29,10:30AM,Abbott Hosts Conference Call for First-Quarter Earnings,0.0,1.0,0.0,0.0
23,ABT,2021-03-28,06:15AM,3 Stocks for the 2020s,0.0,1.0,0.0,0.0
24,ABT,2021-03-26,12:17PM,The Rockefeller Foundation teams up with testing companies to aid school reopenings,0.0,1.0,0.0,0.0
25,ABT,2021-03-26,09:24AM,We've Changed Our Strategy on Abbott Laboratories,0.0,1.0,0.0,0.0
26,ABT,2021-03-26,08:16AM,"The Zacks Analyst Blog Highlights: Becton, Dickinson and Co, Cardinal Health, Abbott Lab, Hologic and Bio-Rad Lab",0.0,1.0,0.0,0.0
27,ABT,2021-03-26,06:08AM,"Got $1,400? 3 COVID Stocks to Buy and Hold for the Long Term",0.0,1.0,0.0,0.0
28,ABT,2021-03-26,04:00AM,"'Mad Money' Lightning Round: Yelp, Abbott Laboratories",0.348,0.652,0.0,-0.4939
29,ABT,2021-03-25,09:10AM,Cardinal Health (CAH) Hits New 52-week High: What's Driving It?,0.0,1.0,0.0,0.0
30,ABT,2021-03-25,09:06AM,Why You Should Retain Varian (VAR) in Your Portfolio Now,0.0,1.0,0.0,0.0
31,ABT,2021-03-25,08:47AM,5 MedTech Growth Stocks Gaining Ground in 2021 Amid Pandemic,0.0,0.565,0.435,0.6597
32,ABT,2021-03-25,07:43AM,MedTech to Gain From Economic Stimulus Bill: 3 Stocks to Buy,0.0,0.726,0.274,0.5267
33,ABT,2021-03-24,11:06AM,"NEOGEN's (NEOG) Earnings Miss Estimates in Q3, Margins Up",0.167,0.833,0.0,-0.1531
34,ABT,2021-03-24,09:31AM,Abbott (ABT) Nutrition Shows Robust Momentum Amid Pandemic,0.0,0.745,0.255,0.34
35,ABT,2021-03-24,08:19AM,"The Zacks Analyst Blog Highlights: Abbott Laboratories, AstraZeneca, Booking, Vertex Pharmaceuticals and Yum China",0.0,1.0,0.0,0.0
36,ABT,2021-03-23,02:38PM,"Top Analyst Reports for Abbott, AstraZeneca & Booking Holdings",0.0,0.795,0.205,0.2023
37,ABT,2021-03-23,01:27PM,Here's Why You Should Hold on to Tandem Diabetes (TNDM) Stock,0.0,1.0,0.0,0.0
38,ABT,2021-03-23,08:56AM,Intersect ENT (XENT) Hit by Low ENT Office Visits Amid COVID-19,0.174,0.826,0.0,-0.2732
39,ABT,2021-03-22,04:05AM,Veeva (VEEV) Application Completes Consent for First Patient (Revised),0.0,0.808,0.192,0.2263
40,ABT,2021-03-21,10:01AM,Is Abbott Laboratories (ABT) Stock A Buy or Sell?,0.0,1.0,0.0,0.0
41,ABT,2021-03-19,07:19AM,Could Abbott Laboratories Be a Millionaire-Maker Stock?,0.0,1.0,0.0,0.0
42,ABT,2021-03-19,06:00AM,This Is Why Abbott Labs Is a Great Stock to Buy Right Now,0.0,0.728,0.272,0.6249
43,ABT,2021-03-18,03:07PM,ETF looks to help private sector address womens issues,0.0,0.748,0.252,0.4019
44,ABT,2021-03-18,01:15PM,Veeva (VEEV) Application Completes Consent for First Patient,0.0,0.787,0.213,0.2263
45,ABT,2021-03-18,10:40AM,Medtronic (MDT) Gets FDA Nod for Revised Neuromodulation Labeling,0.0,1.0,0.0,0.0
46,ABT,2021-03-17,05:50PM,Abbott (ABT) Stock Sinks As Market Gains: What You Should Know,0.0,0.806,0.194,0.34
47,ABT,2021-03-17,01:56PM,"SHAREHOLDER ALERT: Barr Law Group Investigating VNDA, VLDR, RIDE, and ABT; Shareholders are Encouraged to Contact the Firm",0.0,0.747,0.253,0.6633
48,ABT,2021-03-17,09:36AM,CVS Health (CVS) Extends COVID-19 Testing in Massachusetts,0.0,0.824,0.176,0.128
49,ABT,2021-03-16,01:42PM,"HealthEquity (HQY) Q4 Earnings, Revenues Beat Estimates",0.0,1.0,0.0,0.0
50,ABT,2021-03-16,12:20PM,Why You Should Add Surmodics (SRDX) to Your Portfolio Now,0.0,1.0,0.0,0.0
51,ABT,2021-03-16,07:00AM,These 3 Zero-Effort Stocks Could Make You Rich,0.0,0.625,0.375,0.5574
52,ABT,2021-03-15,12:48PM,Luminex (LMNX) Files EUA Application for New Respiratory Assay,0.0,1.0,0.0,0.0
53,ABT,2021-03-15,12:46PM,Here's Why You Should Retain Allscripts (MDRX) Stock for Now,0.0,1.0,0.0,0.0
54,ABT,2021-03-12,11:30AM,Is Abbott Laboratories (ABT) Stock Outpacing Its Medical Peers This Year?,0.0,1.0,0.0,0.0
55,ABT,2021-03-11,05:45PM,Abbott (ABT) Outpaces Stock Market Gains: What You Should Know,0.0,0.789,0.211,0.34
56,ABT,2021-03-11,09:00AM,"Abbott Announces its Pandemic Defense Coalition: A Global Network of Expert Collaborators Designed To Help Prevent Future Pandemics, Currently Searching for COVID-19 Variants",0.0,0.782,0.218,0.5106
57,ABT,2021-03-09,11:27AM,Here's Why You Should Retain AMN Healthcare (AMN) Stock Now,0.0,1.0,0.0,0.0
58,ABT,2021-03-09,09:16AM,Abbott (ABT) Launches Telehealth Tool for Neuromodulation,0.0,1.0,0.0,0.0
59,ABT,2021-03-08,09:22AM,What Does Abbott's Debt Look Like?,0.278,0.444,0.278,0.0
60,ABT,2021-03-08,09:00AM,"Abbott Introduces NeuroSphere Virtual Clinic, First-of-its-Kind Remote Neuromodulation Patient-Care Technology in the U.S.",0.0,1.0,0.0,0.0
61,ABT,2021-03-08,05:51AM,"The Zacks Analyst Blog Highlights: Abbott, Johnson & Johnson, Masimo Corp and Medtronic",0.0,1.0,0.0,0.0
62,ABT,2021-03-08,04:04AM,Abbotts Alinity m Resp-4-Plex Test Cleared For Emergency Use In US; Street Says Buy,0.173,0.733,0.093,-0.296
63,ABT,2021-03-06,01:15AM,Should You Be Adding Abbott Laboratories (NYSE:ABT) To Your Watchlist Today?,0.0,1.0,0.0,0.0
64,ABT,2021-03-05,05:45PM,Abbott (ABT) Gains But Lags Market: What You Should Know,0.194,0.62,0.186,-0.0258
65,ABT,2021-03-05,11:09AM,Abbott's Molecular Assay Gets FDA EUA Approval To Detect SARS-CoV-2 And Flu In One Test,0.139,0.695,0.166,0.128
66,ABT,2021-03-05,09:27AM,UPDATE 1-Abbott's test to distinguish coronavirus and flu viruses gets U.S. authorization,0.191,0.809,0.0,-0.3818
67,ABT,2021-03-05,09:04AM,Cooper Companies (COO) Q1 Earnings & Revenues Top Estimates,0.0,0.795,0.205,0.2023
68,ABT,2021-03-05,09:00AM,"Abbott Receives FDA EUA for Laboratory PCR Assay That Detects and Differentiates SARS-CoV-2, Flu A, Flu B and RSV in One Test - and FDA EUA for Asymptomatic Usage of Alinity m COVID-19 Test",0.152,0.848,0.0,-0.6369
69,ABT,2021-03-05,08:56AM,4 Stocks to Watch as FDA Action Plan Stresses MedTech Digitization,0.25,0.75,0.0,-0.4588
70,ABT,2021-03-04,09:39AM,"National Vision (EYE) Q4 Earnings Top Estimates, Margins Up",0.0,0.648,0.352,0.4215
71,ABT,2021-03-04,09:17AM,Masimo's (MASI) Rad-G with Temperature Receives CE Marking,0.0,1.0,0.0,0.0
72,ABT,2021-03-04,08:38AM,Abbott (ABT) Gets Canadian Nod for FreeStyle Libre Expanded Use,0.0,0.841,0.159,0.1779
73,ABT,2021-03-03,12:42PM,Veeva Systems (VEEV) Q4 Earnings and Revenues Beat Estimates,0.0,1.0,0.0,0.0
74,ABT,2021-03-03,09:35AM,"Patterson Companies (PDCO) Q3 Earnings Top Estimates, Up Y/Y",0.0,0.816,0.184,0.2023
75,ABT,2021-03-03,09:00AM,Abbott Receives Health Canada Authorization Under Interim Order to Expand Use of FreeStyleÂ® Libre System for Pregnant Women in the Hospital and Professional Health Care Settings,0.0,0.814,0.186,0.6705
76,ABT,2021-03-02,04:35PM,Abbott Announces HIV Vaccine Research Findings: 'Another Step Toward Unlocking A Cure',0.0,1.0,0.0,0.0
77,ABT,2021-03-02,08:05AM,Abbott says researchers in the Democratic Republic of Congo have made findings that could lead to HIV vaccine,0.0,1.0,0.0,0.0
78,ABT,2021-03-02,07:45AM,Abbott Researchers Find Rare Group of People With Controlled HIV Who Could Be a Key To Unlocking Cure,0.0,1.0,0.0,0.0
79,ABT,2021-03-02,04:41AM,Top Healthcare Stocks to Buy for 2021,0.0,0.769,0.231,0.2023
80,ABT,2021-03-01,12:45PM,"Is Abbott (ABT) a Solid Growth Stock? 3 Reasons to Think "" Yes """,0.0,0.504,0.496,0.7096
81,ABT,2021-03-01,11:15AM,DENTSPLY SIRONA (XRAY) Q4 Earnings & Revenues Beat Estimates,0.0,1.0,0.0,0.0
82,ABT,2021-03-01,11:11AM,PRA Health (PRAH) Stock Down 2.8% Despite Q4 Earnings Beat,0.0,1.0,0.0,0.0
83,ABT,2021-03-01,10:31AM,Here's Why You Should Add Abbott (ABT) to Your Portfolio,0.0,1.0,0.0,0.0
84,ABT,2021-03-01,09:51AM,"Orthofix's (OFIX) Q4 Earnings Top Estimates, Margin Declines",0.0,0.795,0.205,0.2023
85,ABT,2021-03-01,06:25AM,February Ends in Green Amid Extreme Volatility: 5 Top Picks,0.0,0.816,0.184,0.2023
86,ABT,2021-02-28,06:22AM,3 Great Stocks for Low-Risk Investors,0.0,0.494,0.506,0.6249
87,ABT,2021-02-26,11:30AM,Why Is Abbott (ABT) Up 1% Since Last Earnings Report?,0.0,1.0,0.0,0.0
88,ABT,2021-02-26,10:16AM,"Teleflex (TFX) Beats on Q4 Earnings and Revenues, Margins Fall",0.0,1.0,0.0,0.0
89,ABT,2021-02-26,09:26AM,Glaukos (GKOS) Q4 Earnings and Revenues Surpass Estimates,0.0,1.0,0.0,0.0
90,ABT,2021-02-26,09:22AM,"LHC Group (LHCG) Q4 Earnings Beat Estimates, Revenues Miss",0.167,0.833,0.0,-0.1531
91,ABT,2021-02-26,09:01AM,Allscripts (MDRX) Q4 Earnings and Revenues Beat Estimates,0.0,1.0,0.0,0.0
92,ABT,2021-02-26,08:53AM,"NuVasive's (NUVA) Q4 Earnings Top Estimates, Margin Declines",0.0,0.795,0.205,0.2023
93,ABT,2021-02-25,05:45PM,Abbott (ABT) Stock Moves -0.65%: What You Should Know,0.0,1.0,0.0,0.0
94,ABT,2021-02-24,09:31AM,Top 15 Pharmaceutical Companies With Highest R&D Spending,0.0,0.795,0.205,0.2023
95,ABT,2021-02-23,04:20PM,This Medical Stock Just Retook Its Buy Point On Its Unexpected Earnings Beat,0.0,1.0,0.0,0.0
96,ABT,2021-02-23,09:40AM,This Medical Stock Just Retook Its Buy Point On Unexpected Earnings Beat,0.0,1.0,0.0,0.0
97,ABT,2021-02-19,02:47PM,"Sherwin-Williams: Strong Business, Premium Valuation",0.0,0.548,0.452,0.5106
98,ABT,2021-02-19,01:25PM,Abbott Declares 389th Consecutive Quarterly Dividend,0.0,1.0,0.0,0.0
99,ABT,2021-02-18,07:15AM,J&J Seeks FDA Authorization For Covid Vaccine; Is JNJ Stock A Buy Now?,0.0,1.0,0.0,0.0
